Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to R. Karam et al

Paola Nix1, Erin Mundt, Susan Manley1

  • 1Paola Nix, PhD; Erin Mundt, MS, CGC; Susan Manley, MS, CGC, MBA; Bradford Coffee, PhD; and Benjamin Roa, PhD, Myriad Genetic Laboratories, Salt Lake City, UT.

JCO Precision Oncology
|January 20, 2022
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.

NPJ precision oncology·2024
Same author

Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants.

Cancer genetics·2023
Same author

Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndrome.

Frontiers in oncology·2023
Same author

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.

JCO precision oncology·2022
Same author

Functional RNA Studies Are a Useful Tool in Variant Classification but Must Be Used With Caution: A Case Study of One <i>BRCA2</i> Variant.

JCO precision oncology·2022
Same author

The <i>C. elegans</i> mapping locus <i>rol-9</i> is encoded by a gain-of-function mutation in <i>mlt-11</i>.

microPublication biology·2022